CLOV vs DNLI
Clover Health Investments Corp (CLOV) versus Denali Therapeutics Inc (DNLI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
CLOV currently screens at market cap $1.55B. DNLI currently screens at market cap $2.11B.
Not investment advice. Open the CLOV and DNLI stock pages for the full models.
Not investment advice.